Sign in
Taking people in United StatesNo phase

Assessing Immune Dysfunction in Sepsis

Key facts

Who runs it
University of Minnesota
Where
Minneapolis, United StatesSee the site
Trial code
Status
Recruiting
People taking part
150 people, planned
Started
1 Mar 2026
Expected to end
1 Nov 2028
Type of study
Observational, 3 groups
Treatments tested
  • Observational Only
Record updated
23 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who cannot take part

  • Medication usage that includes immunosuppressive drugs, biologic agents, cytokines, growth factor and interleukins
  • Steroid medication usage of \> 300mg hydrocortisone per day (equivalent of \> 20mg prednisone). Patients with chronic steroid use will be excluded, however patients who have had stress dose steroids administered following admission will be included
  • Known history of chronic hepatitis B (HBV) infection and not on treatment with HBV nucleoside analogues prior to the current hospitalization, or HBV DNA \> 100 IU/mL
  • Participation in another investigational interventional drug study within the past 4 weeks
  • Active cancer with chemotherapy and/or radiation treatment within the past 6 weeks
  • Patients with a history of, or who currently have evidence of autoimmune disease, including but not limited to: myasthenia gravis, Guillain Barré syndrome, systemic lupus erythematosus, multiple sclerosis, scleroderma, ulcerative colitis, Crohn's disease, autoimmune hepatitis, Wegener's granulomatosis, HIV/AIDS, etc
  • Patients with active or a history of acute or chronic lymphocytic leukemia
  • Known history of infection with hepatitis C (HCV) and currently undergoing treatment for HCV infection or has detectable HCV RNA
  • Current pregnancy
  • Current incarceration

Other criteria

  • ICU With Sepsis Inclusion Criteria:
  • Age ≥ 18
  • Presumed diagnosis of sepsis, defined as "patients with life-threatening organ dysfunction caused by a dysregulated host response to infection"
  • Patients in the ICU who meet 2 or more of the quick SOFA (qSOFA) definition along with organ dysfunction:; Respiration rate ≥ 22 breaths/min and/or mechanically ventilated; An alteration in mental status; Systolic blood pressure of less than 100 mm Hg and/or receiving inotropes to maintain blood pressure AND/OR; <!-- -->; An acute change in SOFA score ≥2 points, consequent to the infection (can assume SOFA score = 0 in patients with no pre-existing organ dysfunction); ICU Without Sepsis Inclusion Criteria:
  • Age ≥ 18
  • Patients requiring care at a M Health Fairview ICU due to high acuity of illness and no other evidence of sepsis; Healthy Volunteer Inclusion Criteria
  • Age greater or equal to 18
  • ASA status 1, 2 or 3
  • May include patients who are receiving dialysis in an outpatient setting

Where in United States

  • University of MinnesotaMinneapolis, United StatesContact: Kristine KancansTaking people

About the trial

What the trial wants to find out

Sepsis leads to sustained immune system dysfunction resulting in increased susceptibility to secondary infection while in the hospital or after discharge. Consequently, many of the ~2 million Americans that develop sepsis every year will end up back in the ICU, weeks and months later. The objective of this study is to define the cellular and molecular mechanisms driving the dysfunction and reprogramming of T cells and B cells that mediate cellular and humoral immunity using a combination of phenotypic, functional, genomic, and metabolomic assays.

The 3 groups in the trial

  • ICU Patients with Sepsis

    Treatment: Observational Only

  • ICU Patients without Sepsis

    Treatment: Observational Only

  • Healthy Volunteers

    Treatment: Observational Only

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
23 September 2026